Get startedLog in
    Picture of Theratechnologies logo

    TH — Theratechnologies News Story

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapTurnaround
    All News

    Brief: Theratechnologies Receives Update From FDA On Tesamorelin F8 Supplemental Biologic License Application

    Picture of Theratechnologies logoTheratechnologies
    23/01/2024 12:32
    Jan 23 (Reuters) - Theratechnologies Inc  TH.TO :
    * THERATECHNOLOGIES RECEIVES UPDATE FROM FDA ON TESAMORELIN
F8
SUPPLEMENTAL BIOLOGIC LICENSE APPLICATION
    * THERATECHNOLOGIES INC - FDA CONTINUES TO REVIEW FILE PAST
PRESCRIPTION DRUG USER FEE ACT GOAL DATE OF JANUARY 22, 2024

Source text for Eikon:  ID:nGNX5dWGTx 
Further company coverage:  TH.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Theratechnologies

    See all news